Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
23,711,819
-
Share change
-
+6,559,376
-
Total reported value
-
$138,237,000
-
Price per share
-
$5.83
-
Number of holders
-
52
-
Value change
-
+$40,065,880
-
Number of buys
-
28
-
Number of sells
-
21
Institutional Holders of PROTEOSTASIS THERAPEUTICS IN - COM (PTI) as of Q4 2017
As of 31 Dec 2017,
PROTEOSTASIS THERAPEUTICS IN - COM (PTI) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,711,819 shares.
The largest 10 holders included
NEA Management Company, LLC, Cormorant Asset Management, LLC, JENNISON ASSOCIATES LLC, RTW INVESTMENTS, LP, MILLENNIUM MANAGEMENT LLC, Hillhouse Capital Management, Ltd., FMR LLC, Bain Capital Public Equity Management, LLC, Rock Springs Capital Management LP, and Balyasny Asset Management LLC.
This page lists
52
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.